NEW ACLU REPORT: Despite Marijuana Legalization Black People Still Almost Four Times More Likely To Get Arrested

A TALE OF TWO COUNTRIES: RACIALLY TARGETED ARRESTS IN THE ERA OF MARIJUANA REFORM DETAILS MILLIONS OF RACIALLY TARGETED MARIJUANA ARRESTS MADE BETWEEN 2010-2018

NEW YORK: The American Civil Liberties Union today released a new report showing that Black people are 3.64 times more likely than white people to be arrested for marijuana possession despite comparable marijuana usage rates. Additionally, although the total number of people arrested for marijuana possession has decreased in the past decade, law enforcement still made 6.1 million such arrests over that period, and the racial disparities in arrest rates remain in every state.

The reportA Tale of Two Countries: Racially Targeted Arrests in the Era of Marijuana Reformdetails marijuana possession arrests from 2010 to 2018, and updates our unprecedented national report published in 2013, The War on Marijuana in Black and White. The disturbing findings of this new research show that despite several states having reformed marijuana policy over the last decade, far too much has remained unchanged when it comes to racial disparities in arrests.

Key findings include:

  • Law enforcement made more than 6.1 million marijuana-related arrests form 2010-2018. In 2018 alone, there were almost 700,000 marijuana arrests, which accounted for more than 43 percent of all drug arrests. In 2018, law enforcement made more marijuana arrests than for all violent crimes combined.
  • Despite legalization in a number of states, it is not clear that marijuana arrests are trending downward nationally. Arrest rates have actually risen in the past few years, with almost 100,000 more arrests in 2018 than 2015.
  • In every state, and in over 96 percent of the counties examined, Black people were much more likely to be arrested than white people for marijuana possession. Overall, these disparities have not improved. On average, a Black person is 3.64 times more likely to be arrested for marijuana possession than a white person, even though Black and white people use marijuana at similar rates. In 10 states, Blacks were more than five times more likely to be arrested.
  • In states that legalized marijuana, arrest rates decreased after legalization, however racial disparities still remained.

A Tale of Two Countries: Racially Targeted Arrests in the Era of Marijuana Reform comes at a time when the criminal legal system is overwhelmed by the public health crisis presented by COVID-19 that demands expedited decarcercal action to safeguard the lives of those incarcerated in and employed by jails and prisons. The reforms recommended in this report provide a roadmap for reducing marijuana arrests and criminalization as governors, prosecutors, judges, and other stakeholders across the country grapple with the harms presented by the public health crisis and take steps to release people from jails and prisons.

“Many state and local governments across the country continue to aggressively enforce marijuana laws, disproportionately targeting Black communities,” said Ezekiel Edwards, director of the Criminal Law Reform Project at the ACLU and one of the primary authors of the report. “Criminalizing people who use marijuana needlessly entangles hundreds of thousands of people in the criminal legal system every year at a tremendous individual and societal cost. As a matter of racial justice and sound public health policy, every state in the country must legalize marijuana with racial equity at the foundation of such reform.”

To combat the racial disparities rampant in marijuana-related arrests, the ACLU is calling not only for an end to racialized policing, but also for full legalization of marijuana use and possession and specific measures to ensure legalization efforts are grounded in racial justice. This includes pressing for passage of the MORE Act, which  aims to correct historical injustices of the failed War on Drugs that has terrorized Black communities by decriminalizing marijuana at the federal level, reassessing marijuana convictions, and investment in economically disadvantaged communities.

The full report is available here.

 

Booker-Sanders-Casey Statement on CBO Score of Affordable and Safe Prescription Drug Importation Act

DISTRICT OF COLUMBIA: U.S. Sens. Cory Booker (D-NJ), Bernard Sanders (D-VT), and Bob Casey (D-PA) issued the following joint statement in reaction to the preliminary cost estimate of the Affordable and Safe Prescription Drug Importation Act issued by the Congressional Budget Office:

“We are glad to see the independent Congressional Budget Office recognize that the Affordable and Safe Prescription Drug Importation Act — which will help lower prescription drug costs for millions of Americans by allowing the safe importation of prescription drugs from Canada and other nations — will also save taxpayers $6.8 billion over the next ten years. In addition, our bill will help patients struggling with skyrocketing drug costs save money while ensuring critical consumer safety protections — and providing major benefits for American taxpayers. We hope this CBO score will propel Senate Republicans to act and quickly take up this cost- and life-saving measure.”

In February, Booker, Sanders, and Casey introduced the Affordable and Safe Prescription Drug Importation Act to help lower the rising cost of prescription drugs by allowing Americans to import safe, low-cost medicine from Canada and other advanced countries.

The legislation would instruct the secretary of Health and Human Services to put forward regulations allowing wholesalers, pharmacies and individuals to import qualifying prescription drugs from licensed Canadian sellers. After two years, the secretary would have the authority to permit importation from countries in the Organizations for Economic Co-operation and Development (OECD) with standards for the approval and sale of prescription drugs that are comparable to those in the United States.

The bill includes detailed provisions outlining safeguards and consumer protections that ensure the safety of imported drugs, including FDA certification of foreign sellers, a clear definition of what drugs may be imported and supply chain security requirements.